{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:34:27Z","timestamp":1790091267975,"version":"4.0.1"},"reference-count":9,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DD&amp;T"],"published-print":{"date-parts":[[2025,2,28]]},"DOI":"10.5582\/ddt.2025.01010","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T22:11:41Z","timestamp":1740607901000},"page":"80-82","source":"Crossref","is-referenced-by-count":24,"title":["Suzetrigine: The first Nav1.8 inhibitor approved for the treatment of moderate to severe acute pain"],"prefix":"10.5582","volume":"19","author":[{"given":"Shasha","family":"Hu","sequence":"first","affiliation":[{"name":"Department of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Lyu","sequence":"additional","affiliation":[{"name":"Department of Burn and Plastic Surgery, Weihai Central Hospital Affiliated to Qingdao University, Weihai, Shandong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Pharmacy, Qingdao University, Qingdao, Shandong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Gan TJ, Habib AS, Miller TE, White W, Apfelbaum JL. Incidence, patient satisfaction, and perceptions of post-surgical pain: results from a US national survey. Curr Med Res Opin. 2014; 30:149-160.","DOI":"10.1185\/03007995.2013.860019"},{"key":"2","unstructured":"2. Vertex Announces FDA Approval of JOURNAVX\u2122 (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain. <i>https:\/\/investors.vrtx.com\/news-releases\/news-release-details\/vertex-announces-fda-approval-journavxtm-suzetrigine-first-class<\/i> (accessed February 10, 2025)."},{"key":"3","unstructured":"3. FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain.<i> https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-novel-non-opioid-treatment-moderate-severe-acute-pain<\/i> (accessed February 8, 2025)."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Goodwin G, McMahon SB. The physiological function of different voltage-gated sodium channels in pain. Nat Rev Neurosci. 2021; 22:263-274.","DOI":"10.1038\/s41583-021-00444-w"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Osteen JD, Immani S, Tapley TL, Indersmitten T, Hurst NW, Healey T, Aertgeerts K, Negulescu PA, Lechner SM. Pharmacology and Mechanism of Action of Suzetrigine, a Potent and Selective Na(V)1.8 Pain Signal Inhibitor for the Treatment of Moderate to Severe Pain. Pain Ther. 2025.","DOI":"10.1007\/s40122-024-00697-0"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Jones J, Correll DJ, Lechner SM, et al. Selective Inhibition of Na(V)1.8 with VX-548 for Acute Pain. N Engl J Med. 2023; 389:393-405.","DOI":"10.1056\/NEJMoa2209870"},{"key":"7","unstructured":"7. JOURNAVX (suzetrigine) tablets, for oral use. <i>https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/219209Orig1s000lbl.pdf<\/i> (accessed February 12, 2025)."},{"key":"8","unstructured":"8. Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy. <i>https:\/\/clinicaltrials.gov\/study\/NCT06628908?intr=vx-548&amp;page=2&amp;rank=19<\/i> (accessed February 10, 2025). ."},{"key":"9","unstructured":"9. Suzetrigine (VX-548) Phase 2 results in painful lumbosacral radiculopathy. <i>https:\/\/investors.vrtx.com\/news-releases\/news-release-details\/vertex-announces-results-phase-2-study-suzetrigine-treatment<\/i> (accessed February 10, 2025)."}],"container-title":["Drug Discoveries &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ddt\/19\/1\/19_2025.01010\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T04:25:36Z","timestamp":1741407936000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ddt\/19\/1\/19_2025.01010\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5582\/ddt.2025.01010","relation":{},"ISSN":["1881-7831","1881-784X"],"issn-type":[{"value":"1881-7831","type":"print"},{"value":"1881-784X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"article-number":"2025.01010"}}